Random thoughts from a tired mind ... This link from

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham Chanel5 #6264
348
Random thoughts from a tired mind ...

This link from Chanel5 contains startling numbers.

- 220 people per day die from opioid abuse; 80,000 in 2021 alone;

- Opioid abuse deaths QUADRUPLED in 11 yrs from 2010 to 2021;

- 8% of hospital expenditures is from opioid use disorder; equates to $95 Billion ANNUALLY

- In one year, 2020, the economic toll of the opioid epidemic in the US was $1.5 TRILLION

The CMMS is being mentioned a lot of times. I can't help but think something is in the works. Buy, hey, what do I know? From these numbers is it w/ in the moral framework of a sane human being to deny the use PEMF therapies RecoveryRx? Where is an executive order when you need one? How about all those 'signing statements' presidents are so fond of using? Bringing BIEL into the fold should happen immediately.

Each and every year we, the good 'ole us&a pays 100s of billions of dollars in interest to the Federal Reserve (a private for-profit corporation, NOT federal) in Usury payments. In 2022 that amounted to over $850 Billion in interest only and next year will be more. The recent demise of Suisse Bank prompted the European Union to magically conjure up over 100 Billion Swiss francs (about $100 billion) out of thin air. They did this overnight !! For SVB, making all the depositors 'whole' took less than a week and then allowed SVB to declare bankruptcy in the very same week. Where did that money come from? But RecoveryRx in CMMS? Whoa, buddy, slow down, we need to think about this!

BIEL is ripe for the picking. There is no excuse what-so-ever for this company to be languishing in the bureaucratic morass we call government. The problem is not us. It is not the share count. It is not the management. It is not our business model. We are, as I have stated multiple times, swimming in shark-infested waters. You cannot convince anybody of anything while they, the target audience, is being well-compensated to believe the exact opposite of what you are proposing. It doesn't matter if an individual wants to believe or understand. Conformity is a powerful motivator. Edward Bernays, nephew of Sigmund Freud, wrote a book about it in the 1920s called Propaganda. What is the difference between Propaganda, Sales & Marketing, and Crisis Management you ask? Answer: the shortest distance between two points.

It is about the priorities of the psychopaths who really run things, worldwide. Call me what you will but until you have done the homework, or even a portion of it, I have done for decades on end don't even raise your hand. The problem is the system itself. We have no say in it. Democracy is a fraud. Those who obsess over money are the same monsters who manufacture the money and who own and control the media and set up and control the allopathic medical establishment. Money-Media-Medical. The central problem is worldwide central banking. Usury is Immoral. Period.

Critical thinking is rare, is ridiculed and considered dangerous and threatening. It has all but vanished. Parents have been labeled as 'domestic terrorists' b/c they objected to highly sexualized material being offered and taught in elementary schools. We are living in a hell created by these by these sick and diseased minds. See anything a little off here? We, WE!!! , can do better. It starts w/ you. Say no once in a while. Dutiful compliance is the elixir that fuels their insanity.

We are not helpless but we act like it out of fear; of losing our job, of being isolated, of being mocked; of being shunned, of not fitting in. Everything we do, however small, plays a part. We must work w/ what we have and do what we are able to do. You can't give up the fight b/c there is a chance of losing. If we don't fight at all then you guarantee defeat. We are in a fight for our lives. We are wearing regulation boxing gloves playing fair and square. The other side, a tiny minority, has a steel fist covered w/ brass knuckles all covered in velvet and have paid-off the referees and judges.

https://wakeup-world.com/2011/05/20/jfks-spee...societies/ - History will validate this as one of the very best. More than likely contributed to his murder. A coup-d'etat that changed the world. JFK was not perfect but who is? But he understood what he was talking about. He knew. If you have not heard it before, do so.
Quote:
“We are opposed around the world by a monolithic and ruthless conspiracy that relies primarily on covert means for expanding its sphere of influence — on infiltration instead of invasion, on subversion instead of elections, on intimidation instead of free choice, on guerrillas by night instead of armies by day”

“It is a system which has conscripted vast human and material resources into the building of a tightly knit, highly efficient machine that combines military, diplomatic, intelligence, economic, scientific and political operations”

Kick ass, BIEL! Godspeed to Kelly, Keith, Richard, et. al.

Later, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading